Author Archives: davidrcurry

The Impact of COVID-19 Pandemic Lockdown on Routine Immunization in the Province of Laghman, Afghanistan

Posted on by

Risk Management and Healthcare Policy
https://www.dovepress.com/risk-management-and-healthcare-policy-archive56
[Accessed 07 May 2022]

 

Original Research
The Impact of COVID-19 Pandemic Lockdown on Routine Immunization in the Province of Laghman, Afghanistan
Abid Z, Castro Delgado R, Cernuda Martinez JA, Arcos González P
Risk Management and Healthcare Policy 2022, 15:901-908
Published Date: 5 May 2022

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa

Posted on by

Science
Volume 376| Issue 6593| 6 May 2022
https://www.science.org/toc/science/current

 

Research Articles
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
BY Juliet R. C. Pulliam, et al.
06 May 2022
Open Access
Analysis of routine surveillance data from South Africa indicates that the Omicron variant of SARS-CoV-2 evades immunity from prior infection.

Standards of Conducts for Biostatisticians and Stem Cell Researchers: A Call for Self-formulated Aspirational Ethics Over Built-in Prohibitive Ethics

Posted on by

Science and Engineering Ethics
Volume 28, issue 2, April 2022
https://link.springer.com/journal/11948/volumes-and-issues/28-2

 

Original Research/Scholarship – Open Access
Standards of Conducts for Biostatisticians and Stem Cell Researchers: A Call for Self-formulated Aspirational Ethics Over Built-in Prohibitive Ethics
Keiko Sato & Mika Suzuki
Published: 17 March 2022
Abstract
We proposed the Standards of Conducts to provide a general framework that will serve as the basis for guiding each biostatistician and stem cell researcher to formulate their personal standards, rather than as rules with which they are required to comply. Given the responsibility and characteristics of their work, they are expected to maintain independence and work autonomously as professionals. Each of the Standards of Conducts comprises a preamble, mission and values to uphold, Standards of Conducts (10 items), and background. When one internalizes “self-formulated” standards, to make excuses for oneself would be akin to a self-betrayal; responsible actions can be anticipated. If one begins and continues to consider “who I am and what do I work for,” this will become their inner energy, and a source of motivation and pride to inspire oneself. In addition, this aspirational style might help citizens to recognize the autonomous stance of the professional body and that they share the same values.

SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review

Posted on by

Vaccine
Volume 40, Issue 18 Pages 2525-2646 (20 April 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/18

 

Review article Full text access
SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review
Wen Loong Paul Yuen, Sir Young James Loh, Dehao Bryan Wang
Pages 2546-2550

Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005–2021

Posted on by

Vaccine
Volume 40, Issue 18 Pages 2525-2646 (20 April 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/18

 

Research article Abstract only
Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005–2021
Xiaoxue Liu, Wenzhou Yu, Zundong Yin, Lance Rodewald, … Lingsheng Cao
Pages 2561-2567

Healthcare worker perspectives on COVID-19 vaccines: Implications for increasing vaccine acceptance among healthcare workers and patients

Posted on by

Vaccine
Volume 40, Issue 18 Pages 2525-2646 (20 April 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/18

 

Research article Full text access
Healthcare worker perspectives on COVID-19 vaccines: Implications for increasing vaccine acceptance among healthcare workers and patients
Christine M. Thomas, Kelly Searle, Alma Galván, Amy K. Liebman, … William M. Stauffer
Pages 2612-2618

Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study

Posted on by

Vaccine
Volume 40, Issue 18 Pages 2525-2646 (20 April 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/18

 

Research article Open access
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study
Susanna Esposito, Jos Nauta, Giulia Lapini, Emanuele Montomoli, Serge van de Witte
Pages 2626-2634

Pre-Print Servers

Posted on by

Pre-Print Servers

 

Gates Open Research
https://gatesopenresearch.org/browse/articles

Research Article metrics
Revised
The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 2; peer review: 2 approved, 1 approved with reservations]
Megan Auzenbergs, Holly Fountain, Grace Macklin, Hil Lyons, Kathleen M O’Reilly
Peer Reviewers Yvonne Maldonado; Walter A. Orenstein; Svea Closser
Funder
Bill and Melinda Gates Foundation
LATEST VERSION PUBLISHED 05 May 2022

Research Article metrics AWAITING PEER REVIEW
Sexual and reproductive health and rights knowledge, perceptions, and experiences of adolescent learners from three South African townships: qualitative findings from the Girls Achieve Power (GAP Year) Trial [version 1; peer review: awaiting peer review]
Melanie Pleaner, Cecilia Milford, Alison Kutywayo, Nicolette Naidoo, Saiqa Mullick
Peer Reviewers Invited
Funder
Bill and Melinda Gates Foundation
PUBLISHED 03 May 2022

 

medRxiv
https://www.medrxiv.org/content/about-medrxiv
medRxiv is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. medRxiv is for the distribution of preprints – complete but unpublished manuscripts – that describe human health research conducted, analyzed, and interpreted according to scientific principles…

Estimates of excess mortality for the five Nordic countries during the Covid-19 pandemic 2020-2021
Kasper Planeta Kepp, Jonas Planeta Bjork, Kristoffer T Baek, Tea Lallukka
medRxiv 2022.05.07.22274789; doi: https://doi.org/10.1101/2022.05.07.22274789

Assessing the feasibility of sustaining a ‘Zero-COVID’ policy in China in the era of highly transmissible variants
Yan Wang, Kaiyuan Sun, Zhaomin Feng, Lan Yi, Yanpeng Wu, Hengcong Liu, Quanyi Wang, Marco Ajelli, Cecile Viboud, Hongjie Yu
medRxiv 2022.05.07.22274792; doi: https://doi.org/10.1101/2022.05.07.22274792

Comparing human and AI performance in medical machine learning: An open-source Python library for the statistical analysis of reader study data
Scott Mayer McKinney
medRxiv 2022.05.06.22274773; doi: https://doi.org/10.1101/2022.05.06.22274773

Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021
Brendan Day, David Menschik, Deborah Thompson, Christopher Jankosky, John Su, Pedro Moro, Craig Zinderman, Kerry Welsh, Narayan Nair
medRxiv 2022.05.05.22274695; doi: https://doi.org/10.1101/2022.05.05.22274695

School immunization coverage during the COVID-19 pandemic: A retrospective cohort study
Hannah Sell, Yuba Raj Paudel, Donald Voaklander, Shannon E MacDonald
medRxiv 2022.05.04.22274665; doi: https://doi.org/10.1101/2022.05.04.22274665

Deep learning identified genetic variants associated with COVID-19 related mortality
Zihuan Liu, Wei Dai, Shiying Wang, Yisha Yao, Heping Zhang
medRxiv 2022.05.05.22274731; doi: https://doi.org/10.1101/2022.05.05.22274731

A quasi-experimental cohort study evaluating a conditional economic incentive on first-dose COVID-19 vaccination rates among older adults in South Africa
Candice Maylene Chetty-Makkan, Harsha Thirumurthy, Elizabeth F Bair, Simamkele Bokolo, Candy Day, Korstiaan Wapenaar, Jesse Werner, Lawrence Long, Brendan Maughan-Brown, Sophie J S Pascoe, Jacqui Miot, Alison Buttenheim
medRxiv 2022.05.06.22274712; doi: https://doi.org/10.1101/2022.05.06.22274712

COVID-19 vaccine effectiveness during a prison outbreak when the Omicron was the dominant circulating variant, Zambia, December 2021
John Simwanza, Jonas Z. Hines, Danny Sinyange, Nyambe Sinyange, Chilufya Mulenga, Sarah Hanyinza, Patrick Sakubita, Nelia Langa, Haggai Nowa, Priscilla Gardner, Ngonda Saasa, Gabriel Chipeta, James Simpungwe, Warren Malambo, Busiku Hamainza, Nathan Kapata, Muzala Kapina, Kunda Musonda, Mazyanga Liwewe, Consity Mwale, Sombo Fwoloshi, Lloyd B. Mulenga, Simon Agolory, Victor Mukonka, Roma Chilengi
medRxiv 2022.05.06.22274701; doi: https://doi.org/10.1101/2022.05.06.22274701

Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study
Lior Rennert, Zichen Ma, Christopher McMahan, Delphine Dean
medRxiv 2022.05.06.22274771; doi: https://doi.org/10.1101/2022.05.06.22274771

Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study
Lior Rennert, Zichen Ma, Christopher McMahan, Delphine Dean
medRxiv 2022.05.06.22274771; doi: https://doi.org/10.1101/2022.05.06.22274771

Uganda Genome Resource: A rich research database for genomic studies of communicable and non-communicable diseases in Africa
Segun Fatumo, Joseph Mugisha, Opeyemi Soremekun, Allan Kalungi, Richard Mayanja, Christopher Kintu, Ronald Makanga, Ayoub Kakande, Andrew Abaasa, Gershim Asiki, Robert Kalyesubula, Robert Newton, Moffat Nyirenda, Manjinder S Sandhu, Pontiano Kaleebu
medRxiv 2022.05.05.22274740; doi: https://doi.org/10.1101/2022.05.05.22274740

The spread and burden of the COVID-19 pandemic in sub-Saharan Africa: comparison between predictions and actual data and lessons learned
Christophe Dongmo Fokoua-Maxime, Yahia Bellouche, Dillonne Ngonpong Tchigui-Ariolle, Tchana Loic Tchato-Yann, Simeon Pierre Choukem
medRxiv 2022.05.04.22274692; doi: https://doi.org/10.1101/2022.05.04.22274692

Antibody responses to AZD1222 vaccination in West Africa
Adam Abdullahi, David Oladele, Steven A. Kemp, James Ayorinde, Abideen Salako, Fehintola Ige, Douglas Fink, Chika Onwuamah, Qosim Osuolale, Rufai Abubakar, Azuka Okuruawe, Gideon Liboro, Oluwatosin Odubela, Gregory Ohihoin, Oliver Ezechi, Olagoke Usman, Sunfay Mogaji, Adedamola Dada, Soraya Ebrahimi, Lourdes Ceron Gutierrez, Sani H. Aliyu, Rainer Doffinger, Rosemary Audu, Richard Adegbola, Petra Mlcochova, Babatunde Lawal Solako, Ravindra K. Gupta
medRxiv 2022.05.04.22274668; doi: https://doi.org/10.1101/2022.05.04.22274668

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: a modelling study
Allison Portnoy, Rebecca A. Clark, Matthew Quaife, Chathika K. Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K. Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C.W. Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G. White, Nicolas A. Menzies
medRxiv 2022.05.04.22274654; doi: https://doi.org/10.1101/2022.05.04.22274654

Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries
Maria Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, Riccardo Levi, Maximiliano Mollura, Riccardo Sarti, Miguel Angel Sanz-Sánchez, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Gerardo Francisco Del Rio-Parra, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Elena Azzolini, Riccardo Barbieri, Alessandro Rodrigo de Azevedo Dias, Milton Henriques-Guimaraes Júnior, Alessandra Bastos-Borges, Cecilia Acciardi, Graciela Paez-Bo, Mauro Martins Teixeira, Maria Rescigno
medRxiv 2022.03.11.22272153; doi: https://doi.org/10.1101/2022.03.11.22272153 Revision

Mondo: Unifying diseases for the world, by the world
Nicole A Vasilevsky, Nicolas A Matentzoglu, Sabrina Toro, Joseph E Flack IV, Harshad Hegde, Deepak R Unni, Gioconda F Alyea, Joanna S Amberger, Larry Babb, James P Balhoff, Taylor I Bingaman, Gully A Burns, Orion J Buske, Tiffany J Callahan, Leigh C Carmody, Paula Carrio Cordo, Lauren E Chan, George S Chang, Sean L Christiaens, Louise C Daugherty, Michel Dumontier, Laura E Failla, May J Flowers, H. Alpha Garrett Jr., Jennifer L Goldstein, Dylan Gration, Tudor Groza, Marc Hanauer, Nomi L Harris, Jason A Hilton, Daniel S Himmelstein, Charles Tapley Hoyt, Megan S Kane, Sebastian Köhler, David Lagorce, Abbe Lai, Martin Larralde, Antonia Lock, Irene López Santiago, Donna R Maglott, Adriana J Malheiro, Birgit H M Meldal, Monica C Munoz-Torres, Tristan H Nelson, Frank W Nicholas, David Ochoa, Daniel P Olson, Tudor I Oprea, David Osumi-Sutherland, Helen Parkinson, Zoë May Pendlington, Ana Rath, Heidi L Rehm, Lyubov Remennik, Erin R Riggs, Paola Roncaglia, Justyne E Ross, Marion F Shadbolt, Kent A Shefchek, Morgan N Similuk, Nicholas Sioutos, Damian Smedley, Rachel Sparks, Ray Stefancsik, Ralf Stephan, Andrea L Storm, Doron Stupp, Gregory S Stupp, Jagadish Chandrabose Sundaramurthi, Imke Tammen, Darin Tay, Courtney L Thaxton, Eloise Valasek, Jordi Valls-Margarit, Alex H Wagner, Danielle Welter, Patricia L Whetzel, Lori L Whiteman, Valerie Wood, Colleen H Xu, Andreas Zankl, Xingmin Aaron Zhang, Christopher G Chute, Peter N Robinson, Christopher J Mungall, Ada Hamosh, Melissa A Haendel
medRxiv 2022.04.13.22273750; doi: https://doi.org/10.1101/2022.04.13.22273750 Revision

Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages
Houriiyah Tegally, Monika Moir, Josie Everatt, Marta Giovanetti, Cathrine Scheepers, Eduan Wilkinson, Kathleen Subramoney, Sikhulile Moyo, Daniel G. Amoako, Cheryl Baxter, Christian L. Althaus, Ugochukwu J. Anyaneji, Dikeledi Kekana, Raquel Viana, Jennifer Giandhari, Richard J. Lessells, Tongai Maponga, Dorcas Maruapula, Wonderful Choga, Mogomotsi Matshaba, Simnikiwe Mayaphi, Nokuzola Mbhele, Mpaphi B. Mbulawa, Nokukhanya Msomi, NGS-SA consortium, Yeshnee Naidoo, Sureshnee Pillay, Tomasz Janusz Sanko, James E. San, Lesley Scott, Lavanya Singh, Nonkululeko A. Magini, Pamela Smith-Lawrence, Wendy Stevens, Graeme Dor, Derek Tshiabuila, Nicole Wolter, Wolfgang Preiser, Florette K. Treurnicht, Marietjie Venter, Michaela Davids, Georginah Chiloane, Adriano Mendes, Caitlyn McIntyre, Aine O’Toole, Christopher Ruis, Thomas P. Peacock, Cornelius Roemer, Carolyn Williamson, Oliver G. Pybus, Jinal Bhiman, Allison Glass, Darren P. Martin, Andrew Rambaut, Simani Gaseitsiwe, Anne von Gottberg, Tulio de Oliveira
medRxiv 2022.05.01.22274406; doi: https://doi.org/10.1101/2022.05.01.22274406

Vaccine Stockpile Sharing For Selfish Objectives
Shashwat Shivam, Joshua S. Weitz, Yorai Wardi
medRxiv 2022.04.28.22274446; doi: https://doi.org/10.1101/2022.04.28.22274446

Wellcome Open Research [to 07 May 2022]
https://wellcomeopenresearch.org/browse/articles
[Accessed 07 May 2022]

Wellcome Open Research provides all Wellcome researchers with a place to rapidly publish any results they think are worth sharing. All articles benefit from rapid publication, transparent peer review and editorial guidance on making all source data openly available.

Research Note metrics AWAITING PEER REVIEW
A longitudinal analysis comparing the proportion of children with excess weight before and during the COVID-19 pandemic [version 1; peer review: awaiting peer review]
Gillian Santorelli, John Wright, Duncan Cooper, Laura Lennon, Sarah Muckle, Jane West
Peer Reviewers Invited
Funders
Economic and Social Research Council
British Heart Foundation
Wellcome
National Institute for Health Research
Medical Research Council
Prevention Research Partnership
NIHR Clinical Research Network
PUBLISHED 06 May 2022

Think Tanks

Posted on by

Think Tanks
 
 
Brookings [to 07 May 2022]
http://www.brookings.edu/
Accessed 07 May 2022
Latest Research
Coronavirus (COVID-19)
Dismantling the ivory tower’s knowledge boundaries
Jacqueline N. Lane and Hila Lifshitz-Assaf
Tuesday, May 3, 2022
A call for open access as the new normal in the social sciences post-COVID

In response to the COVID-19 crisis, governments, policymakers, foundations, publishers, and researchers poured significant resources into scientific knowledge production on COVID-19 and its impacts while also expanding access to such research. The emphasis on the “open access” publishing model—a set of principles and practices through which research outputs are distributed online, free of cost and access barriers—was a boon to researchers studying the crisis and society in general, dismantling disciplinary and socio-economic boundaries within academia as well as boundaries between academia and the general public. By embracing the open access publishing model outside times of crisis, we could dismantle those boundaries permanently, leading to immeasurable benefits for society…
 
 
Center for Global Development [to 07 May 2022]
https://www.cgdev.org/
Research [Selected]
[No new digest content identified]
 
 
Chatham House [to 07 May 2022]
https://www.chathamhouse.org/
Accessed 07 May 2022
[No new digest content identified]
 
 
CSIS [to 07 May 2022]
https://www.csis.org/
Accessed 07 May 2022
Upcoming Event
An Exit Interview with Henrietta Fore, former Executive Director of UNICEF
May 10, 2022

 
 
Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 07 May 2022
May 4, 2022 News Release
1 in 5 Parents of Children Under 5 Intend to Get Them a COVID-19 Vaccine Right Away Once Eligible; Most Say Approval Delays Have Not Shaken Their Confidence in Vaccine’s Safety and Effectiveness
About a Third of the Public Thinks the Nation is Facing a New COVID-19 Wave as Cases Rise About a fifth (18%) of parents with children under age 5 say they intend to get their child vaccinated “right away” once federal regulators authorize its use for their child’s age group,…
 
 
ODI [Overseas Development Institute] [to 07 May 2022]
https://odi.org/en/publications/
Publications
Accessed 07 May 2022
[No new digest content identified]
 
 
Rand [to 07 May 2022]
https://www.rand.org/pubs.html
Reports, Selected Journal Articles
[No new digest content identified]
 
 
Urban Institute [to 07 May 2022]
https://www.urban.org/publications
Research Publications
Brief
The Pandemic’s Effects on Early Educators’ Employment and Well-Being
May 5, 2022

Vaccines and Global Health: The Week in Review :: 07 May 2022

Posted on by

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here:

vaccines-and-global-health_the-week-in-review_07-mayl-2022Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

Vaccines and Global Health: The Week in Review :: 23 April 2022

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here:

vaccines-and-global-health_the-week-in-review_23-april-2022_final-1Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

Vaccines and Global Health: The Week in Review :: 30 April 2022

Posted on by

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here:

vaccines-and-global-health_the-week-in-review_30-april-2022-1Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

Vaccines and Global Health: The Week in Review :: 23 April 2022

Vaccines and Global Health: The Week in Review is a weekly digest  summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated with the current issue date

.– Request an Email Summary: Vaccines and Global Health : The Week in Review is published as a single email summary, scheduled for release each Saturday evening before midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.

– pdf version:  A pdf of the current issue is available here:

vaccines-and-global-health_the-week-in-review_23-april-2022_final-1Download

– blog edition: comprised of the approx. 35+ entries posted below.

– Twitter:  Readers can also follow developments on twitter: @vaxethicspolicy.
.
– Links:  We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.

Support this knowledge-sharing service: Your financial support helps us cover our costs and to address a current shortfall in our annual operating budget. Click here to donate and thank you in advance for your contribution.

.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy

UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children

Posted on by

Measles

UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children
Reported worldwide measles cases increased by 79 per cent in the first two months of 2022, compared to the same period in 2021, as WHO and UNICEF warn conditions ripe for serious outbreaks of vaccine-preventable illnesses

NEW YORK/ GENEVA, 27 April 2022 – An increase in measles cases in January and February 2022 is a worrying sign of a heightened risk for the spread of vaccine-preventable diseases and could trigger larger outbreaks, particularly of measles affecting millions of children in 2022, warn WHO and UNICEF.

 

Pandemic-related disruptions, increasing inequalities in access to vaccines, and the diversion of resources from routine immunization are leaving too many children without protection against measles and other vaccine-preventable diseases.

The risk for large outbreaks has increased as communities relax social distancing practices and other preventive measures for COVID-19 implemented during the height of the pandemic. In addition, with millions of people being displaced due to conflicts and crises including in Ukraine, Ethiopia, Somalia and Afghanistan, disruptions in routine immunization and COVID-19 vaccination services, lack of clean water and sanitation, and overcrowding increase the risk of vaccine-preventable disease outbreaks.

Almost 17,338 measles cases were reported worldwide in January and February 2022, compared to 9,665 during the first two months of 2021. As measles is very contagious, cases tend to show up quickly when vaccination levels decline. The agencies are concerned that outbreaks of measles could also forewarn outbreaks of other diseases that do not spread as rapidly…

 

In 2020, 23 million children missed out on basic childhood vaccines through routine health services, the highest number since 2009 and 3.7 million more than in 2019…

…As countries work to respond to outbreaks of measles and other vaccine-preventable diseases, and recover lost ground, UNICEF and WHO, along with partners such as Gavi, the Vaccine Alliance, the partners of the Measles & Rubella Initiative (M&RI), Bill & Melinda Gates Foundation, and others are supporting efforts to strengthen immunization systems by:
Restoring services and vaccination campaigns so countries can safely deliver routine immunization programmes to fill the gaps left by the backsliding;
Helping health workers and community leaders communicate actively with caregivers to explain the importance of vaccinations;
Rectifying gaps in immunization coverage, including identifying communities and people who have been missed during the pandemic;
Ensuring that COVID-19 vaccine delivery is independently financed and well-integrated into overall planning for immunization services so that it is not carried out at the cost of childhood and other vaccination services;
Implementing country plans to prevent and respond to outbreaks of vaccine-preventable diseases and strengthening immunization systems as part of COVID-19 recovery efforts.

1 in 4 children in Latin America and the Caribbean are exposed to diseases that can be prevented with vaccines

Posted on by

PAHO

1 in 4 children in Latin America and the Caribbean are exposed to diseases that can be prevented with vaccines
PANAMÁ CITY, 25 April 2022 – In five years, the complete vaccination schedule for diphtheria, tetanus and pertussis (DTP3) in Latin America and the Caribbean has dropped from 90 percent in 2015 to 76 percent in 2020, according to data from the Pan American Health Organization (PAHO) and UNICEF. This means that one in four children in the region has not received the full routine vaccination schedule that would protect them from multiple diseases.

The decrease in vaccination coverage precedes the pandemic; but the cessation or irregular programming of many primary health care services during the pandemic and people’s fear of catching COVID19 during visits to health centers is leaving many children without vaccines.

“The decline in vaccination rates in the region is alarming and puts millions of children and adolescents at risk of dangerous diseases that could be prevented,” said Jean Gough, UNICEF Regional Director for Latin America and Caribbean. “The solution, and it has been proven to be effective: stronger vaccination programmes.”

 

The 14 percentage point drop in vaccine coverage leaves nearly 2.5 million children without the complete DTP vaccination schedule and they are at risk of dangerous preventable diseases. Of them, 1.5 million are “zero doses”: they have not even received the first dose of that vaccine.

Dangerous setback
The decrease in coverage exposes more children to the resurgence of preventable diseases and epidemiological outbreaks have already occurred. In example, while in 2013 only 5 people in the region got diphtheria, in 2018 almost 900 cases were registered, according to PAHO data. Measles sets higher alarms because it is caused by a highly contagious virus: in 2013 there were almost 500 cases; but in 2019, more than 23,000 people got the disease.

“As countries recover from the pandemic, immediate actions are needed to prevent coverage rates from further dropping, because the re-emergence of disease outbreaks poses a serious risk to all of society,” Gough said. “This is an opportunity to restructure primary health care and reinforce the comprehensive and community approach that bring vaccines to the most vulnerable populations. We cannot lose the efforts of past decades and let dangerous diseases threaten the lives of children.”

UNICEF calls on the governments of Latin America and the Caribbean to urgently re-establish and strengthen routine immunization programs, develop campaigns to increase vaccine confidence and implement plans to reach all children and adolescents and their families; especially to the most vulnerable who do not have access to health services, due to their geographic location, migratory status or ethnic identity.

Keynote Address: Breaking the Cycle of Neglect and Panic

Posted on by

Keynote Address: Breaking the Cycle of Neglect and Panic
Date: April 27, 2022 Type: Speeches and Transcripts

We are meeting to discuss the issues of preparedness and response after more than two years of a global Pandemic. Although the situation has improved, we still need to be cautious given the case numbers in some countries and the low level of vaccination in some parts of the World.

The past two years have brought a lot of hardship: in terms lives lost, impacts on livelihoods and economic opportunities, and the impact on Human Capital through school closures and basic health services. This has further raised concerns about the state of preparedness of the world, and our collective ability to break the cycle of Panic and Neglect.

This is more urgent given what we know about the state of the world. In 2021, the Global Health Security Index showed the extent of the challenge with 70% of countries showed insufficient capacity to respond to health emergencies and deliver essential health services in clinics, hospitals, and community health centers. The pandemic revealed stark disparities in the capacity of countries to prevent and respond to COVID-19 bringing into sharp focus significant under-investments in pandemic preparedness which has amplified inequalities at all levels and highlighted the urgent need for collective action.

 

A recent Bank paper shows that most low- and middle-income countries are already facing tremendous fiscal pressures from the ongoing pandemic and will not be able to mobilize the huge sums necessary for investing in preparedness nor for strengthening their health systems.

To respond to these challenges the global community has shown a strong willingness to lean forward.

Indeed, the IDA20 replenishment, which was hosted by Japan, has culminated in a package which includes ambitious commitments to support countries to strengthen pandemic preparedness and response. The preparedness agenda is front and center of this IDA round.

The G20 and G7 have recently endorsed a new Financial Intermediary Fund (FIF) to strengthen preparedness and response. The FIF is meant to complement the current offerings and close remaining gaps in support of countries around the world.

Furthermore, there is broader and growing awareness of the One Health approach, which offers a framework to think about prevention and preparedness at country level. For instance, this is something that we are reflecting more and more in our World Bank portfolio through entry-points in the agriculture and environment sectors.

All of these efforts have to build on what we know works, and complement it in order to provide needed resources to countries who will have to address many gaps with limited fiscal space and competing needs. This requires collaboration and strong partnerships amongst all of us. No single actor or plan can do it alone.

This is where the Health Emergency Preparedness and Response Program is comes with its mission to catalyze, complement and connect. It has a critical role to play in the network of services and support we are building for our clients. I want here to thank Japan, Australia and Germany for their financing for and partnership in the HEPR program…

…Today’s session provides a valuable forum to delve deeper into the progress made through the HEPR Program funded efforts since the it was approved 18 months ago and the work ahead. It also affords an important opportunity to hear from leaders on the frontlines in countries and communities – essential voices from whom we must all learn as we chart the way forward.

Before I hand over to the team, I would like to leave with two thoughts:
:: First, we need to make strong analytical work at country and global levels a priority. Indeed, key indicators and analysis, as well as in depth work to understand country context will be important to guide policy and investments, but also raise the awareness on what is needed.
:: Second, although there is a momentum now around the agenda of preparedness, this can be sidelined very quickly by other emerging priorities. I count on all partners here to help make sure we maintain the push, and that we all advocate for preparedness to be streamlined throughout all aspects of the recovery.

I look forward to listening to our many partners and friends gathered here today for this event, from the Ministers of Health of Eswatini, Guyana, Togo, and partners from Japan, Australia, WHO and the Africa Center of Excellence for Genomics of Infectious Diseases.

COVID Vaccines – Humanitarian Buffer(HB)

Posted on by

COVID Vaccines – Humanitarian Buffer(HB)

“Broken” humanitarian COVID-19 vaccine system delays vaccinations – MSF
MSF Press Release 27 Apr 2022
People in parts of northern Syria faced delays to receiving COVID-19 vaccinations earlier this year due to an unwieldy humanitarian vaccination system.
The COVAX mechanism is failing the people it is meant to serve due to opaque legal frameworks and unfair liability demands.
MSF urges the COVAX partners – who include WHO, UNICEF and Gavi – to immediately fix the system and enable people timely access to vaccines.

The COVID-19 vaccine Humanitarian Buffer(HB) is failing its mission to support people hit by the pandemic and struggling to access immunisation, says Médecins Sans Frontières (MSF). The HB is part of the COVAX mechanism*, whose aim is to assist groups of people who do not have access to COVID-19 vaccination in situations of humanitarian emergency. However, MSF’s recent experience in northern Syria has highlighted the system’s limitations and ultimate failure to fulfil its purpose.

In late 2021, when the Delta variant was still predominant, MSF teams observed a significant increase in the number of reported COVID-19 cases in Tell Abyad and Ras Al-Ain. The area, currently under Turkish control, is home to approximately 156,000 people, including almost 70,000 people in need according to the United Nations. Due to its status, the area is not included neither in the UN’s cross-border mechanism for the delivery of humanitarian aid, nor covered by the Syrian government’s national immunisation roll-out plan.

In November of the same year, MSF submitted an application to the UN-led humanitarian emergency COVID-19 vaccine reserve with a view to launching an immunisation campaign in collaboration with our Syrian NGO partner, Al Ameen. However, once the application was approved approximately six weeks after its submission, MSF was confronted with an opaque, unwieldy legal framework placing an excessive liability on field-based humanitarian organisations carrying out the operations. This led to months of consuming contractual wrangling, until the Turkish authorities made alternative plans and the window closed on the opportunity for MSF and Al Ameen to run the planned immunisation campaign.

“For this system to work and allow for a timely intervention, it has to be practical and fair for all partners,” says Sarah Chateau, MSF’s Programme Manager for Syria. “When we started discussing with the rest of the COVAX partners, we realised it was definitely not the case.”

“To start with, we were denied access to some of the legal documents framing the procurement, which were necessary for us to assess the risks we were asked to accept,” explains Chateau.

Another significant obstacle was the deeply unbalanced distribution of liabilities in the initial version of the agreement framing the supply of the vaccines, which led to months of negotiations. In those agreements, UNICEF, Gavi (the global vaccine alliance) and the vaccine manufacturer transferred to MSF part of their liability for their own roles and responsibilities in the HB, requesting MSF to waive some of our legal avenues against them and, in some cases, indemnify them against their loss and third-party claims. Adding to this, the sheer number of contracts and interlocutors results in a lack of overall accountability for the overall functioning of the system.

As of March 2022, 2.5 million doses have been approved through the humanitarian buffer according to publicly available information and while more applications are in process, this is a small fraction of the 155 million doses announced at the beginning of 2022 as the HB target.

“The Humanitarian Buffer can potentially support millions of people, particularly among hard-to-reach groups of people,” says Chateau. “For the sake of our collective pandemic preparedness, we urge the COVAX partners to work to improve the system: unacceptably lengthy negotiations, excessive contractual complexity, lack of transparency and the unbalanced distribution of liabilities are issues that need an urgent solution.”

“We appreciate the concept of the HB,” says Chateau. “But the system today is failing its purpose and, more importantly, the people it is meant to serve.”

Coronavirus [COVID-19] – WHO

Posted on by

::::::

 

Coronavirus [COVID-19] – WHO
Public Health Emergency of International Concern (PHEIC)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019

 

Weekly Epidemiological and Operational updates
Last update: 29 Apr 2022
Confirmed cases :: 510 270 667
Confirmed deaths :: 6 233 526
Vaccine doses administered: 11 438 720 838

 

::::::

Weekly epidemiological update on COVID-19 – 27 April 2022
Overview
Globally, the number of new COVID-19 cases and deaths has continued to decline since the end of March 2022.
During the week of 18 through 24 April 2022, over 4.5 million cases and over 15 000 deaths were reported, decreases of 21% and 20% respectively, as compared to the previous week. However, an increase in the number of new weekly cases was reported from the Regions of the Americas (+9%) and the African Region (+32%), and the number of new weekly deaths increased in the South-East Asia Region (+41%), due to a delay in reporting of deaths from India, and in the Africa Region (+110%).
As of 24 April 2022, over 500 million confirmed cases and over six million deaths have been reported globally.
In this edition, we provide an update on the geographic distribution of circulating SARS-CoV-2 variants of concern (VOCs), including the prevalence and summary of current evidence of the Omicron variant. We also provide updates on vaccine effectiveness for the Delta and Omicron variants.

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 02 April 2022
[New additions; Full scale view available at title link above]
[Updated on 30 Apr 2022]
::::::

COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements

Posted on by

COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]

 

AstraZeneca
Press Releases – No new digest announcements identified

Bharat Biotech
Press Releases
Apr 26: COVAXIN® for Children: India approves COVAXIN® in Children 6-12 years
COVAXIN is the one of the first COVID-19 vaccines in the world to generate data in 2-18
year age group.
COVAXIN was earlier approved for children 12-18 years of age.
Whole-Virion inactivated SARS-CoV-2 Vaccine (BBV152) has proven to be safe, welltolerated,
and immunogenic in paediatric subjects in phase II/III study in children 2-18 years
of age.
Neutralizing antibodies in children on were 1.7 times higher than in adults.
No serious adverse event was reported. Pain at the injection site was the most commonly
reported adverse event. No cases of myocarditis or blood clots were reported, as is to be
expected with inactivated vaccines.
COVAXIN exhibits robust immune responses in children with 2 doses and 6 months follow
up, indicating durability of immune responses. Data was presented to the CDSCO Subject
Expert Committee and will be published in the weeks to come.
Hyderabad, April 26, 2022: Bharat Biotech International Limited (BBIL), a global leader in vaccine
innovation and developer of vaccines for infectious diseases, today announced that BBV152
(COVAXIN), its whole-virion inactivated COVID-19 vaccine candidate, has received emergency use
approval in children 6-12 years of age…

BioCubaFarma – Cuba
Últimas Noticias – Website not leading at inquiry

 

Biological E
News –
BE’s CORBEVAXTM Gets DCGI Nod for Emergency Use in 5-12 Years
:: The approval comes soon after CORBEVAXTM was given the nod for 12-15-year group
::As part of its Phase 2/3 clinical trials in 312 children aged between 5 and 12 years, Biological E administered two doses of 0.5 ml each of CORBEVAXTM or Placebo in 28 days’ gap
– April 26, 2022

 

Biontech
Press Releases
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age
26 April 2022

 

CanSinoBIO
News – Website not responding at inquiry

 

CIGB
Latest News – No new digest announcements identified

 

Cinagen
Recent News
Researchers announced safety and effectiveness of ReciGen (interferon beta-1a 44 mcg manufactured by CinnaGen Co.) on COVID-19 patients
20 June 2020

Clover Biopharmaceuticals – China
News – No new digest announcements identified

 

Curevac [Bayer Ag – Germany]
News – No new digest announcements identified

 

Gamaleya National Center
Latest News and Events – See Russia below.

IMBCAMS, China
Home – Website not responding at inquiry

 

Janssen/JNJ
Press Releases – No new digest announcements identified

 

Medicago
Media – No new digest announcements identified

 

Moderna
Press Releases
29 April, 2022
Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union

29 April, 2022
Moderna Finalizes Plan for Long-Term Strategic Partnership with The Government of Canada
:: Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
:: The ten-year strategic partnership is expected to provide Canadians with rapid response capabilities to ensure future pandemic readiness

28 April, 2022
Moderna Files for Authorization of Its COVID-19 Vaccine in Young Children Six Months to Under Six Years of Age

 

Nanogen
News – No new digest announcements identified

 

Novavax
Press Releases
Apr 29, 2022
FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax’ COVID-19 Vaccine
NVX-CoV2373 would be the first protein-based COVID-19 vaccine to be reviewed by VRBPAC in the U.S.
GAITHERSBURG, Md., April 29, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) will review NVX-CoV2373 COVID-19 Vaccine (recombinant, adjuvanted) for active immunization against SARS-CoV-2 at a meeting scheduled for June 7, 2022..

 

Pfizer
Recent Press Releases
April 29, 2022
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVID™ for Post-Exposure Prophylactic Use

04.26.2022
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age

04.26.2022
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

 

R-Pharm
https://rpharm-us.com/index.php
[No news or media page identified]

 

Sanofi Pasteur
Press Releases – No new digest announcements identified

 

Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified

Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.

 

Sinopharm/WIBPBIBP
News – No new digest announcements identified

 

Sinovac
Press Releases
China NMPA approved SINOVAC Omicron-specific vaccine for clinical trial
2022/04/26

 

Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified

 

WestVac Biopharma
Media – No new digest announcements identified

Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]

 

::::::

GSK
Press releases for media
29 April 2022
SK bioscience and GSK’s adjuvanted COVID-19 vaccine candidate meets coprimary objectives in a phase III study; Biologics License Application submitted for SKYCovione™(GBP510/GSK adjuvant) in South Korea

 

Merck
News releases – No new digest announcements identified

 

Novartis
News – No new digest announcements identified

 

SK Biosciences
Press Releases
SK bioscience and GSK’s Adjuvanted COVID-19 Vaccine Candidate Meets Coprimary Objectives in a Phase III Study; Biologics License Application Submitted for SKYCovione™(GBP510/GSK adjuvant) in South Korea
2022.04.29

SK bioscience Reports Positive Phase III Immunogenicity Results of Its Adjuvanted Covid-19 Vaccine Clinical Trial of COVID-19 Vaccine, AS03-adjuvanted
2022.04.25

 

Valneva
Press Releases
April 26, 2022
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

April 26, 2022
Valneva Provides Regulatory Update on its inactivated COVID-19 Vaccine Candidate

COVID-19 Global Targets and Progress Tracker – IMF

Posted on by

COVID-19 Global Targets and Progress Tracker – IMF
The COVID-19 Global Targets and Progress Tracker presents a consolidated view of the progress towards global COVID-19 targets, barriers in access to COVID-19 tools, and delivery of donor pledges.

The global targets presented in the Tracker are based on an alignment of the targets identified in the IMF Pandemic Proposal, ACT-A Strategic Plan & Budget, and the US-hosted Global C19 Summit, and as such have been reaffirmed by multilateral institutions and global leaders. We will continue to enhance the tracker as we improve our data collection efforts.

Global Dashboard on COVID-19 Vaccine Equity

Posted on by

Global Dashboard on COVID-19 Vaccine Equity
The Dashboard is a joint initiative of UNDP, WHO and the University of Oxford with cooperation across the UN system, anchored in the SDG 3 Global Action Plan for Healthy Lives and Well-being for All.

Dashboard on Vaccine Equity [accessed 30 Apr 2022]: https://data.undp.org/vaccine-equity/
See also visualization on Vaccine Access and Vaccine Affordability

Duke – Launch and Scale Speedometer

Posted on by

Duke – Launch and Scale Speedometer
The Race for Global COVID-19 Vaccine Equity
A flurry of nearly 200 COVID-19 vaccine candidates are moving forward through the development and clinical trials processes at unprecedented speed; more than ten candidates are already in Phase 3 large-scale trials and several have received emergency or limited authorization. Our team has aggregated and analyzed publicly available data to track the flow of procurement and manufacturing and better understand global equity challenges. We developed a data framework of relevant variables and conducted desk research of publicly available information to identify COVID vaccine candidates and status, deals and ongoing negotiations for procurement and manufacturing, COVID burden by country, and allocation and distribution plans. We have also conducted interviews with public officials in key countries to better understand the context and challenges facing vaccine allocation and distribution
[accessed 24 July 2021]
See our COVID Vaccine Purchases research
See our COVID Vaccine Manufacturing research
See our COVID Vaccine Donations & Exports research

COVID Vaccines – OCHA:: HDX

Posted on by

COVID Vaccines – OCHA:: HDX

COVID-19 Data Explorer: Global Humanitarian Operations
COVID-19 Vaccine Roll-out
30 Apr 2022 | COVAX (WHO,GAVI,CEPI), UNDESA, Press Reports | DATA
Global COVID-19 Figures: 510M total confirmed cases; 6.2M total confirmed deaths
Global vaccines administered: 11.6B
Number of Countries: 28
COVAX Allocations Round 4-9 (Number of Doses): 170M
COVAX Delivered (Number of Doses): 290M
Other Delivered (Number of Doses): 300M
Total Delivered (Number of Doses): 590M
Total Administered (Number of Doses): 380M

Multilateral Leaders Task Force on COVID-19 [IMF, World Bank Group, WHO, WTO]

Posted on by

Multilateral Leaders Task Force on COVID-19 [IMF, World Bank Group, WHO, WTO]
https://data.covid19taskforce.com/data
A global effort to help developing countries access and deliver COVID-19 vaccines, testing, and therapeutics, as they work to end the pandemic and boost economic recovery.
The International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization have joined forces to accelerate access to COVID-19 vaccines, therapeutics and diagnostics by leveraging multilateral finance and trade solutions, particularly in low- and middle-income countries.
Website accessed 30 Apr 2022: https://data.covid19taskforce.com/data The global view below is complemented by country-specific dashboards here.

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Posted on by

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

HHS
News
No new digest content identified.

 

BARDA-ASPR – U.S. Department of HHS [to 30 Apr 2022]
https://aspr.hhs.gov/newsroom/Pages/NewsRoomHome.aspx
News
ASPR funding expands manufacturing capacity for prefilled injectors to administer vaccines, medicines
Thursday, April 21, 2022

 

 

::::::

 

FDA
Press Announcements
April 25, 2022 – Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children
Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms (about 7 pounds) with positive results of direct SARS-CoV-2 viral testing, who are:
:: Hospitalized, or
:: Not hospitalized and have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19, including hospitalization or death.
This action makes Veklury the first approved COVID-19 treatment for children less than 12 years of age. As a result of today’s approval action, the agency also revoked the emergency use authorization for Veklury that previously covered this pediatric population…

Regulatory Actions
Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee
Calendar
April 29, 2022 – Coronavirus (COVID-19) Update: FDA Announces Tentative Advisory Committee Meeting Schedule Regarding COVID- 19 Vaccines
Today, the U.S. Food and Drug Administration is announcing its plans to hold virtual meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) in anticipation of complete submissions of emergency use authorization (EUA) requests in the coming months that have been publicly announced by COVID-19 vaccine manufacturers.

It is important to note that the dates below are tentative as none of the submissions are complete. The agency understands the urgency to authorize a vaccine for age groups who are not currently eligible for vaccination and will work diligently to complete our evaluation of the data. Should any of the submissions be completed in a timely manner and the data support a clear path forward following our evaluation, the FDA will act quickly and anticipates convening the following VRBPAC meetings:

On June 7, FDA intends to convene VRBPAC to discuss an EUA request for a COVID-19 vaccine manufactured by Novavax to prevent COVID-19 in individuals 18 years of age and older.

 

On June 8, 21 and 22, the FDA has held dates for the VRBPAC to meet to discuss updates to the Moderna and Pfizer-BioNTech EUAs for their COVID-19 vaccines to include younger populations. As the sponsors complete their submissions and the FDA reviews that data and information, it will provide additional details on scheduling of the VRBPAC meetings to discuss each EUA request.

 

On June 28, the FDA plans to convene the VRBPAC to discuss whether the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified, and if so, which strain(s) should be selected for Fall 2022. This meeting is a follow-up to the April 6 VRBPAC meeting that discussed general considerations for future COVID-19 vaccine booster doses and the strain composition of COVID-19 vaccines to further meet public health needs.

“As we continue to address the ongoing COVID-19 pandemic, there are a number of anticipated submissions and scientific questions that will benefit from discussion with our advisory committee members,” said Peter Marks, M.D., Ph.D., director of the Center for Biologics Evaluation and Research. “We are providing a tentative schedule for discussion of these submissions, as these meetings will cover a number of topics that are of great interest to the general public. The agency is committed to a thorough and transparent process that considers the input of our independent advisors and provides insight into our review of the COVID-19 vaccines. We intend to move quickly with any authorizations that are appropriate once our work is completed.”

Once the meeting dates are finalized, the FDA intends to make background materials available to the public, including the meeting agenda and committee roster, no later than two business days before each meeting…

 

 

::::::

 

White House [U.S.] [to 30 Apr 2022]
Briefing Room – Selected Major COVID Announcements
Press Statement – COVID Context
Fact Sheet: Biden Administration Underscores Urgent Need for Additional COVID-⁠19 Response Funding and the Severe Consequences of Congressional Inaction
April 27, 2022 • Statements and Releases

Press Briefing by Press Secretary Jen Psaki and White House COVID-⁠19 Response Coordinator Dr. Ashish Jha
April 26, 2022 • Press Briefings

FACT SHEET: Biden Administration Increases Access to COVID-⁠19 Treatments and Boosts Patient and Provider Awareness
April 26, 2022 • Statements and Releases

Background Press Call by Senior Administration Officials on New Actions to Increase Access to COVID-⁠19 Treatments and Boost Patient and Provider Awareness
April 25, 2022 • Press Briefings

 

USAID [to 30 Apr 2022]
https://www.usaid.gov/news-information/press-releases
Selected Press Releases, Statements, Announcements
The United States Provides an Additional $13.9 Million to Support Madagascar
April 29, 2022
The United States through the U.S. Agency for International Development (USAID) is providing an additional $13.9 million in funding to Madagascar. Of the $13.9 million in new funding, $5.4 million will go to the country’s COVID-19 response, and $8.5 million will support small and medium enterprises and economic empowerment for people with disabilities.

The United States Provides an Additional $13.9 Million to Support Madagascar
April 29, 2022
The United States through the U.S. Agency for International Development (USAID) is providing an additional $13.9 million in funding to Madagascar. Of the $13.9 million in new funding, $5.4 million will go to the country’s COVID-19 response, and $8.5 million will support small and medium enterprises and economic empowerment for people with disabilities.

2022 Interagency Report on the Implementation of the Presidential Memorandum on Advancing the Human Rights of LGBTQI+ Persons Around the World
April 28, 2022
Statement by Administrator Samantha Power
I applaud the release of the historic 2022 U.S. Interagency Report on the Implementation of the Presidential Memorandum on Advancing the Human Rights of LGBTQI+ Persons Around the World. The report puts a timely spotlight on affirmative efforts of the U.S. government, in partnership with LGBTQI+ leaders, civil-society organizations, rights advocates, and a range of partners, to defend the human rights and dignity of LGBTQI+ persons in every region of the world and across sectors.

Biden Administration Announces Hundreds of Millions of Dollars in Global Food Aid to Respond to Putin’s Unprovoked Invasion of Ukraine
April 27, 2022
Today, the Biden Administration announced that the U.S. Agency for International Development (USAID) and the U.S. Department of Agriculture (USDA) are taking the extraordinary step to draw down the full balance of the Bill Emerson Humanitarian Trust (BEHT) as part of an effort to provide $670 million in food assistance to countries in need as a result of Putin’s unprovoked invasion of Ukraine. The world is suffering from historic levels of global food insecurity, which is being exacerbated by the impact Russia’s war on Ukraine is having on global food supplies. Available estimates suggest that an additional 40 million people could be pushed into poverty and food insecurity as a result of Russia’s aggression.

United States Providing More Than $200 Million in Additional Humanitarian Assistance for the Horn of Africa
April 26, 2022
Today in Geneva, the United States announced more than $200 million in additional assistance to respond to humanitarian needs in the Horn of Africa, including from the devastating drought and to address the needs of refugees, internally displaced persons, and conflict-affected population in the region. This assistance, through the U.S. Agency for International Development (USAID) and the U.S. Department of State will help save lives in Ethiopia, Kenya, and Somalia, where more than 20 million people are projected to need emergency food assistance this year following two years of inadequate rainfall in a region dependent on agriculture and livestock to survive.

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Posted on by

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

European Medicines Agency
News & Press Releases
Press Releases
News: European Immunization Week 2022: Statement by Executive Director Emer Cooke – Why vaccines contribute to a “Long Life for All” (new)
Last updated: 25/04/2022

 

 

::::::

 

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates [Selected]
Publication
Hepatitis of unknown origin – Reporting protocol 2022
Technical guidance – 29 Apr 2022
This reporting protocol is intended for reporting national case-based data for surveillance of hepatitis of unknown origin from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA), to the European level.

 

 

::::::

Accessed 29 Apr 2022
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

 

 

::::::

 

European Commission
https://ec.europa.eu/commission/presscorner/home/en
Latest [Selected]
Statement 29 April 2022
Commission statement on the resignation of Fabrice Leggeri [Frontex]

Press release 28 April 2022
EU and international partners put forward a Declaration for the Future of the Internet
Today, the European Union, the United States, and several international partners have proposed a Declaration for the Future of the Internet, setting out the vision and principles of a trusted Internet.

Speech 27 April 2022 Brussels
Speech by Vice-President Jourová on abusive lawsuits against journalists and human rights defenders ‘SLAPPs‘

Press release 26 April 2022
Food security in Horn of Africa: EU steps up support to drought-affected countries
A devastating climate-induced drought is affecting the Horn of Africa. The situation is worsened by the impact of COVID-19, conflict and insecurity situation in the region, as well as the expected aggravation of food insecurity and nutrition due to Russia’s invasion of Ukraine.

Press release 25 April 2022
Russian war crimes in Ukraine: Commission proposes to reinforce the mandate of Eurojust to collect and preserve evidence of war crimes
Today, the Commission has proposed to amend the Eurojust Regulation to give the Agency the legal possibility to collect, preserve and share evidence on war crimes.

India: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Posted on by

India: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

 

Ministry of Health and Family Welfare
https://www.mohfw.gov.in/

 

 

Government of India – Press Information Bureau
Latest Press Releases
COVID – 19 Vaccination Update – Day 470
:: India’s cumulative vaccination coverage crosses 189 Crore landmark milestone
:: More than 23 lakh Vaccine doses administered today till 7 pm
Posted On: 30 APR 2022 8:02PM by PIB Delhi

 

 

Indian Council for Medical Research (ICMR)
https://www.icmr.gov.in/media.html
Press Releases
No new digest content identified.

China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Posted on by

China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

[We did not identify official announcements about Shanghai confirming the reports below; See China CDC below for additional announcements]

Shanghai marks COVID milestone, Beijing on edge
By Brenda Goh and Min Zhang
Shanghai records no COVID cases outside quarantine areas
Beijing on tenterhooks, bracing for more restrictions
Breakthrough would mark victory for Xi in crucial year
Infections ease as China starts Labour Day holiday

SHANGHAI/BEIJING, April 30 (Reuters) – Shanghai said on Saturday it had detected no new daily COVID-19 cases outside quarantine areas, marking a milestone in its battle to contain the virus, which has paralysed the city of 25 million and put residents in the capital Beijing on edge.

Streets in Beijing were eerily quiet at the start of a five-day Labour Day break, with residents anxious that authorities would impose further restrictions during a holiday when many typically travel or socialise…

…Beijing will also implement a further two rounds of COVID tests on May 1 and May 3 in its most populous district of Chaoyang, known for its night life, malls and embassies.

The city will halt all restaurant dining between May 1 and 4, an official from the local commerce bureau said, calling for residents to “cook at home”.

Officials have provided no timeline or strategy for returning to some semblance of normality.

 

 

Nomura estimates 46 cities are in full or partial lockdowns, affecting 343 million people. Societe Generale estimates that provinces experiencing significant restrictions account for 80% of China’s economic output.

In response to COVID and other headwinds, China will step up policy support for the economy, a top decision-making body of the Communist Party said on Friday, lifting stocks from two-year lows. read more

Shanghai reported 47 COVID-19 deaths for Friday, down from 52 a day earlier. Some have questioned the fatality rate, as many residents have said relatives or friends have died after catching coronavirus as early as March.

Beijing has reported 295 new COVID-19 cases since April 22, the local health authority said, of which 123 cases were found in the Chaoyang district.

Overall, mainland China reported 10,793 daily COVID-19 cases, down from 15,688 new cases a day earlier, the National Health Commission said on Saturday…

GPEI Polio

Posted on by

GPEI Polio

Polio this week as of 27 April 2022
Headlines
:: This week, Global Polio Eradication Initiative (GPEI) partners launched the ‘Investment Case’ for polio eradication, at a virtual event.  The Investment Case is the GPEI sister-document to the Polio Eradication Strategy 2022-2026, and outlines the humanitarian and economic benefits of polio eradication.  During the event, the Government of Germany, which holds G7 presidency in 2022, announced that the country will co-host a pledging moment for the GPEI Strategy during the 2022 World Health Summit in October.  A recording of the virtual event is available online here.

:: Rotary International President Shekhar Mehta, WHO GPEI Director Aidan O’Leary and Dr Sarthak Das, Chief Executive Officer of the Asia Pacific Leaders Malaria Alliance offer their views on what lessons and experiences from polio and malaria can be drawn for existing and future pandemics, in an op-ed published in Health Policy Watch.  Read it here.
:: Comprehensive outbreak response in Tajikistan successfully stops outbreak:  an outbreak response assessment concluded that a cVDPV2 outbreak that started in January 2021 has been stopped, thanks to comprehensive and rapid response with novel oral polio vaccine type 2 (nOPV2).  More

 

Summary of new polioviruses this week:
– Pakistan: one WPV1 case and one positive environmental sample
– DR Congo: four cVDPV2 cases
– Israel: 13 cVDPV3 positive environmental samples
– Nigeria: one cVDPV2 case
– Occupied Palestinian territory: seven cVDPV3 positive environmental samples
– Somalia: one cVDPV2 case

 

Polio transition planning and polio post-certification
27 April 2022  Meeting report
Overview
The Executive Board at its 150th session noted an earlier version of this report.1 The present report provides an update on the implementation of the Strategic Action Plan on Polio Transition (2018–2023)2 at the start of 2022, within the context of the coronavirus disease (COVID-19) pandemic.

UN OCHA – Current Emergencies

Posted on by

UN OCHA – Current Emergencies
Current Corporate Emergencies
Afghanistan
No new updates identified.

 

Northern Ethiopia
Ethiopia – Northern Ethiopia Humanitarian Update Situation Report, 29 Apr 2022
HIGHLIGHTS
3,400 MT of food brought into Tigray between 1 and 25 April. At least 4,675 MT of food are required every day to complete current food distribution by mid-May.
More than 46,000 students across 144 schools in Wag Hemra Zone, South Wello, North Wello Oromia zones of Amhara Region received school feeding services during the reporting week.
Some 16,500 IDPs in Amhara Region have been assisted with essential NFI kits during this reporting week.
82,884 people received food assistance in Fanti Raise and Kilbati Rasu zones in Afar during the reporting period and overall 698,503 peopl assisted as of 25 April.

Ukraine
Ukraine: Humanitarian Impact Situation Report (As of 12:00 p.m. (EET) on 26 April 2022)

WHO & Regional Offices [to 30 Apr 2022]

Posted on by

WHO & Regional Offices [to 30 Apr 2022]
https://www.who.int/news
News [Selected]
29 April 2022
Statement
Quadripartite Memorandum of Understanding (MoU) signed for a new era of One Health collaboration

27 April 2022
Joint News Release
UNICEF and WHO warn of perfect storm of conditions for measles outbreaks, affecting children
[See Milestones above for detail]

27 April 2022
Departmental news
WHO launches a second report of country success stories in mitigating the impact of the COVID-19 pandemic on TB services

::::::

WHO Director General Speeches [selected]
https://www.who.int/director-general/speeches
Selected
27 April 2022
Speech
WHO Director-General’s opening remarks at the 10th meeting of the Access to COVID-19 Tools Accelerator Facilitation Council – 26 April 2022

27 April 2022
Speech
WHO Director-General’s remarks at the Investment Case for Polio Eradication – 26 April 2022

27 April 2022
Speech
WHO Deputy Director-General’s speech at the OECD Council on the 2030 Agenda for Sustainable Development: Session 2: Global health challenges in the era of COVID-19

26 April 2022
Speech
WHO Director-General’s opening remarks at the WHO press conference – 26 April 2022

25 April 2022
Speech
WHO Director-General’s panel remarks at the Group of Friends of Global Health – 25 April 2022

25 April 2022
Speech
WHO Director-General’s opening remarks at the Working Group on Sustainable Finance, final meeting – 25 April 2022

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region
:: 29 April 2022 Ghana finds success in COVID-19 mass vaccination campaigns
:: 29 April 2022 Speedy vaccination campaign helps stop cholera outbreak in Niger
:: 28 April 2022 Vaccine-preventable disease outbreaks on the rise in Africa

WHO Region of the Americas PAHO
:: 29 Apr 2022
Environmental surveillance – complementary tool for tracking COVID-19
Over 60 countries, including several in the Americas, are using wastewater monitoring to track SARS-CoV-2 in communities, with over 3,300 active sites. Washington, D.C., April 29, 2022 (PAHO) — New guidance from the World Health Organization (WHO) provides advice to countries on sampling and testing for the SARS-CoV2 virus in untreated…

:: 25 Apr 2022
PAHO Director calls for immunization gaps to be closed for all vaccines, including COVID-19
2.7 million children in the Americas did not receive the vaccines needed to keep them healthy in 2020, while around 230 million people have still not received a single dose of COVID-19 vaccine in the region Roseau, Dominica, 25 April 2022 (PAHO) – In 2020, 2.7 million children in the Americas did not receive the essential vaccines needed to keep…

:: 25 Apr 2022
World Malaria Day – More must be done to improve malaria response at the local level
Washington D.C., 25 April 2022 (PAHO) – On World Malaria Day, the Pan American Health Organization (PAHO) urges countries to step-up efforts to tackle malaria in the region, calling for prevention, diagnosis and treatment interventions that are data-led and tailored to local contexts. While in 2020, the 18 endemic countries of the Americas…

WHO South-East Asia Region SEARO
No new digest content identified.

WHO European Region EURO
:: WHO re-assigns Islands and Small States Institute in Malta as collaborating centre 29-04-2022
:: HPV vaccination brings the WHO European Region closer to a cervical cancer-free future 29-04-2022
:: Comprehensive outbreak response successfully stops spread of polio in Tajikistan 28-04-2022
:: Ukraine: Immediate steps needed to prevent a measles outbreak due to the ongoing war and low vaccination rates, warns WHO 28-04-2022
:: Countries across the WHO European Region celebrate World Health Day 2022 27-04-2022

WHO Eastern Mediterranean Region EMRO
:: WHO marks 5 years of strategic partnership with USAID in Iraq 26 April 2021

WHO Western Pacific Region
:: 25 April 2022 News release
WHO announces winners of inaugural Western Pacific Innovation Challenge

 

::::::

Disease Outbreak News (DONs)
Latest WHO Disease Outbreak News (DONs), providing information on confirmed acute public health events or potential events of concern.
28 April 2022 | Ebola virus disease – Democratic Republic of the Congo

28 April 2022 | Japanese encephalitis – Australia

27 April 2022 | Multi-country outbreak of Salmonella Typhimurium linked to chocolate products – Europe and the United States of America

27 April 2022 | Cholera – Malawi

27 April 2022 | Measles – Somalia

25 April 2022 | Yellow Fever – Uganda

 

::::::

WHO Events
https://www.who.int/news-room/events/1
[Selected]
Indigenous peoples and tackling health inequities: WHO side event at the 21st session of the UN Permanent Forum on Indigenous Issues
3 May 2022 17:00 – 18:30 CET

 

Launch of the Child Health and Well Being Dashboard
4 May 2022 15:30 – 17:00 CET

 

::::::

New WHO Publications
https://www.who.int/publications/i
Selected Titles
28 April 2022
Integration of mental health and HIV interventions

28 April 2022
Emergency in Ukraine: external situation report #9, published 28 April 2022: reporting period: 21–27…

27 April 2022
Polio transition planning and polio post-certification
Overview
The Executive Board at its 150th session noted an earlier version of this report.1 The present report provides an update on the implementation of the Strategic Action Plan on Polio Transition (2018–2023)2 at the start of 2022, within the context of the coronavirus disease (COVID-19) pandemic.

27 April 2022
Strengthening pandemic preparedness planning for respiratory pathogens: policy brief, 27 April 2022
Overview
This policy brief outlines core elements that Member States are encouraged to a) develop an integrated approach to respiratory pathogen pandemic preparedness planning and b) enhance national and sub-national functional capacities for preparedness. In addition, this policy brief highlights suggested actions for Member States as they initiate or update national and sub-national pandemic preparedness planning process.

25 April 2022
Infection prevention and control in the context of coronavirus disease (‎COVID-19)‎: a living guideline, 25 April 2022: updated chapter: mask use, part 1: health care settings

25 April 2022
WASH FIT: A practical guide for improving quality of care through water, sanitation and hygiene in health…

25 April 2022
Integrated care for older people (ICOPE) implementation pilot programme

MMWR  Weekly: Current Volume (71) April 29 2022 / No. 17

Posted on by

MMWR  Weekly: Current Volume (71) April 29 2022 / No. 17
PDF of this issue
Public Health Actions to Control Measles Among Afghan Evacuees During Operation Allies Welcome — United States, September–November 2021
Provisional COVID-19 Age-Adjusted Death Rates, by Race and Ethnicity — United States, 2020–2021
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
Notes from the Field: Response to Measles Among Persons Evacuated from Afghanistan — Joint Base McGuire-Dix-Lakehurst, New Jersey, August–October 2021

Organization Announcements

Posted on by

Organization Announcements

Editor’s Note:

Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

Airfinity    [to  30 Apr 2022]

https://www.airfinity.com/insights

INSIGHTS & COMPANY NEWS

Global sales estimate for COVID-19 antiviral pills increased by 60% to $32.5bn

Published by Airfinity

Apr 21, 2022

   Airfinity has released its latest COVID-19 treatments revenue forecast for Q1 2022 and 2022.

Paul G. Allen Frontiers Group    [to  30 Apr 2022]

https://alleninstitute.org/news-press/

News

News from the Allen Institute: April 2022

April 28, 2022

   Highlights include: a new Lab Notes podcast on why we don’t understand the brain, new research about how neurons connect, day-in-the-life features of our neuroscience labs and more. 

BMGF – Gates Foundation  [to  30 Apr 2022]

https://www.gatesfoundation.org/ideas/media-center

Press Releases and Statements

No new digest content identified.

Bill & Melinda Gates Medical Research Institute    [to  30 Apr 2022]

https://www.gatesmri.org/news

The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people

No new digest content identified.

CARB-X   [to  30 Apr 2022]

Home

News

No new digest content identified.

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation   [to  30 Apr 2022]

https://centerforvaccineethicsandpolicy.net/

News/Analysis/Statements

:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.

:: Informed Consent: A Monthly Review – April 2022is now posted here

:: Statement on ICF [Informed Consent Form] Posting for Clinical Trials Involving Gene Editing/Gene Therapies – Invitation to Endorse

:: Patients, Politics, Pressure :: Pharma Stays Steady [Mostly] In Russia Sanctions Context

Observations at 30 March 2022     David R Curry


CEPI – Coalition for Epidemic Preparedness Innovations  [to  30 Apr 2022]

http://cepi.net/

Latest News

No new digest content identified.

DARPA – Defense Advanced Research Projects Agency [U.S.] [to  30 Apr 2022

https://www.darpa.mil/news

News

No new digest content identified.

Duke Global Health Innovation Center  [to  30 Apr 2022]

Home

Our Blog

No new digest content identified.

EDCTP    [to  30 Apr 2022]

http://www.edctp.org/

The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials

News

29 April 2022

Belgium and Côte d’Ivoire join EDCTP Association

25 April 2022

World Malaria Day 2022: EDCTP supports innovative approaches to fight malaria

Emory Vaccine Center    [to  30 Apr 2022]

http://www.vaccines.emory.edu/

Vaccine Center News

Emory/Georgia funded TRAC by NIAID

NIH Funds New Tuberculosis Research Advancement Centers

European Vaccine Initiative  [to  30 Apr 2022]

http://www.euvaccine.eu/

Latest News, Events

“Vaccines provide everyone a chance at a fulfilling life”

World Immunization Week: 24 – 30 April 2022

Evidence Aid   [to  30 Apr 2022]

Evidence Aid aims to save lives and livelihoods in disasters by providing decision-makers with the best available evidence and by championing its use.

http://www.evidenceaid.org/

New Resources

Prophylactic anticoagulants for hospitalized COVID‐19 patients (search up to 14 April 2021) Added April 25, 2022

Fondation Merieux  [to  30 Apr 2022]

http://www.fondation-merieux.org/

News, Events 

Mérieux Foundation & University of Geneva co-organized event

22nd Advanced Vaccinology Course (ADVAC)

May 9 – 20, 2022 – Les Pensières Center for Global Health, Veyrier-du-Lac (France)

Gavi [to  30 Apr 2022]

https://www.gavi.org/

News Releases

27 April 2022

Amref health Africa appointed by Gavi as the new Civil Society Organisation (CSO) host

GHIT Fund   [to  30 Apr 2022]

https://www.ghitfund.org/newsroom/press

Press Releases

No new digest content identified.

Global Fund  [to  30 Apr 2022]

https://www.theglobalfund.org/en/news/

News & Stories

25 April 2022

Global Fund Urges the World to Boost the Fight Against Malaria as COVID-19 Disruptions, Drug and Insecticide Resistance and New Threats Endanger Progress

   Ahead of World Malaria Day, 25 April, the Global Fund calls for renewed commitment in the fight against malaria, a disease that now kills one child every minute. After years of steady declines, malaria cases and deaths are on the rise mainly due to s…

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to  30 Apr 2022]

Latest News

News

No new digest content identified

Hilleman Laboratories   [to  30 Apr 2022]

http://www.hilleman-labs.org/

News & Insights

No new digest content identified

HHMI – Howard Hughes Medical Institute    [to  30 Apr 2022]

https://www.hhmi.org/news

Press Room                    

No new digest content identified.

Human Vaccines Project   [to  30 Apr 2022]

http://www.humanvaccinesproject.org/

News

No new digest content identified.

IAVI  [to  30 Apr 2022]

https://www.iavi.org/

Latest News

No new digest content identified.

ICRC  [to  30 Apr 2022]

https://www.icrc.org/en/whats-new

What’s New   [Selected]   

Taking COVID-19 vaccines to remote areas in Mindanao

   This is primarily because many are unable to bear the cost of travelling to a vaccine centre in the main city while others fear getting the vaccination owing to misinformation and lack of awareness.As a result, their families and communities remain v

29-04-2022 | Article

ICRC appoints a new member to governing body

   Geneva (ICRC) – At its meeting on 27 April, the Assembly of the International Committee of the Red Cross (ICRC) appointed Ms Samia Hurst-Majno as its newest member.

28-04-2022 | News release

Table of National Committees and other national bodies on international humanitarian law

26 April 2022

International Coalition of Medicines Regulatory Authorities [ICMRA]

http://www.icmra.info/drupal/en/news

Selected Statements, Press Releases, Research

No new digest content identified.

IFFIm

http://www.iffim.org/

Press Releases/Announcements

No new digest content identified.

IFRC   [to  30 Apr 2022]

http://media.ifrc.org/ifrc/news/press-releases/

Press Releases [Selected]

27/04/2022

Vaccinations vital as COVID cripples Pacific countries

    Kuala Lumpur/Suva 28 April 2022 – The International Federation of Red Cross and Red Crescent Societies are increasingly concerned for more than 1 million people in Pacific nations as they struggle with their first major wave of COVID-19 fuelled by the Omicron variants.

   Ramping up vaccinations is vital as the rapid surge in COVID infections is causing increasing death and illness in countries with low immunisation rates.

   COVID-free for almost two years, Vanuatu, the Solomon Islands, Tonga, Kiribati, and Samoa have all experienced outbreaks in their capitals, and the virus is spreading to vulnerable outer island communities which lack basic treatment and vaccination facilities.

   The virus is putting huge strains on fragile healthcare systems in population centres such as Honiara, Port Vila and Nuku’alofa. A rising number of healthcare workers are being struck down with COVID-19, further limiting health services and escalating the crisis…

26/04/2022

KwaZulu-Natal floods: Red Cross steps up response amid mounting humanitarian needs

Institut Pasteur   [to  30 Apr 2022]

https://www.pasteur.fr/en/press-area

Press Documents

No new digest content identified.

IOM / International Organization for Migration [to  30 Apr 2022]   

http://www.iom.int/press-room/press-releases

News – Selected

News  Global

29 April 2022

IOM Appeals for USD 514 Million to Support Ukraine Response

ISC / International Science Council  [to  30 Apr 2022]

https://council.science/current/

ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.

News  Blogs  Podcasts Events

Blogs

Vaccine promotion remains a key focus for this year’s Day of Immunology

29.04.2022

On this International Day of Immunology, join ISC Member the International Union of Immunological Societies (IUIS) in celebrating the theme of vaccines with promotional and educational activities.

International Union of Immunological Societies (IUIS)

Home

News/Events [Selected]

2022 International Day of Immunology

April 26, 2022

IVAC  [to  30 Apr 2022]

https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html

Updates; Events

No new digest content identified.

IVI   [to  30 Apr 2022]

http://www.ivi.int/

IVI News & Announcements

No new digest content identified.

Johns Hopkins Center for Health Security   [to  30 Apr 2022]

https://www.centerforhealthsecurity.org/news/center-news/

Center News

Johns Hopkins Center for Health Security’s COVID-19 Testing Toolkit Launches New FAQs Tool
April 28, 2022

MSF/Médecins Sans Frontières  [to  30 Apr 2022]

http://www.msf.org/

Latest [Selected Announcements]

Sudan

Violent attacks leave tens of thousands without access to healthcare in West Darfur

Project Update 29 Apr 2022

Access to medicines

“Broken” humanitarian COVID-19 vaccine system delays vaccinations

Press Release 27 Apr 2022

[See Perspectives above for detail]

National Academy of Medicine – USA  [to  30 Apr 2022]

Programs

News [Selected]

NAM to Deliver National Plan to Strengthen Health Workforce Well-Being and Restore the Health of the Nation

April 28, 2022

    The National Academy of Medicine (NAM) Action Collaborative on Clinician Well-Being and Resilience is working urgently to develop a National Plan for health workforce well-being. The draft plan will be released in May 2022 for public input and builds on almost six years of collective work among 200 Clinician Well-Being Collaborative members and network organizations. […]

National Academy of Sciences – USA  [to  30 Apr 2022]

http://www.nasonline.org/news-and-multimedia/

News

No new digest content identified.

National Vaccine Program Office – U.S. HHS  [to  30 Apr 2022]

https://www.hhs.gov/vaccines/about/index.html

Upcoming Meetings/Latest Updates                          

No new digest content identified.

NIH  [to  30 Apr 2022]

http://www.nih.gov/

News Releases 

No new digest content identified.

OECD  [to  30 Apr 2022]

http://www.oecd.org/newsroom/publicationsdocuments/bydate/

Newsroom/Library

OECD countries advancing slowly on sustainable development targets by 2030

   Despite progress made since the adoption of the 2030 Agenda for Sustainable Development and its 17 Goals (SDGs), OECD countries have met or are close to meeting only a quarter of the targets for which performance can be gauged, according to a new OECD report.

27 April 2022

PATH  [to  30 Apr 2022]                                     

https://www.path.org/media-center/

Press Releases

No new digest content identified.

Sabin Vaccine Institute  [to  30 Apr 2022]

http://www.sabin.org/updates/pressreleases

Statements and Press Releases

No new digest content identified.

UNAIDS [to  30 Apr 2022]

http://www.unaids.org/en

Selected Press Releases/Reports/Statements

28 April 2022

Key considerations to integrate HIV and mental health interventions

UNHCR Office of the United Nations High Commissioner for Refugees [to  30 Apr 2022]

http://www.unhcr.org/en-us/media-centre.htmlS

Selected News Releases, Announcements

No new digest content identified.

UNICEF  [to  30 Apr 2022]

https://www.unicef.org/media/press-releases

Press Releases, News Notes, Statements  [Selected]

Press release

04/27/2022

UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children

https://www.unicef.org/press-releases/unicef-and-who-warn-perfect-storm-conditions-measles-outbreaks-affecting-children

NEW YORK/ GENEVA, 27 April 2022 – An increase in measles cases in January and February 2022 is a worrying sign of a heightened risk for the spread of vaccine-preventable diseases and could trigger larger outbreaks, particularly of measles affecting millions of children in 2022, warn WHO and UNICEF. Pandemic-related disruptions, increasing…

[See Perspectives above for detail]

Press release

04/26/2022

Global polio eradication initiative calls for renewed commitments to achieve promise of a polio-free world

https://www.unicef.org/press-releases/global-polio-eradication-initiative-calls-renewed-commitments-achieve-promise-polio

GENEVA, 26 April 2022 – Today, the Global Polio Eradication Initiative (GPEI) announced that it is seeking new commitments to fund its 2022-2026 Strategy at a virtual event to launch its investment case. The strategy, if fully funded, will see the vaccination of 370 million children annually for the next five years and the continuation of global…

Press release

04/25/2022

1 in 4 children in Latin America and the Caribbean are exposed to diseases that can be prevented with vaccines

https://www.unicef.org/press-releases/1-4-children-latin-america-and-caribbean-are-exposed-diseases-can-be-prevented

PANAMÁ CITY, 25 April 2022 – In five years, the complete vaccination schedule for diphtheria, tetanus and pertussis (DTP3) in Latin America and the Caribbean has dropped from 90 percent in 2015 to 76 percent in 2020, according to data from the Pan American Health

[See Perspectives above for detail]

Unitaid  [to  30 Apr 2022]

Home

Featured News

No new digest content identified.

Vaccine Equity Cooperative [nee Initiative]   [to  30 Apr 2022]

News

News

No new digest content identified.

Vaccination Acceptance & Demand Initiative [Sabin)  [to  30 Apr 2022]

https://www.vaccineacceptance.org/

Announcements, Blog

World Immunization Week 2022

Working Toward a Long Life for All with Dr. Ashmita Gupta and Dr. Salvia Zeeshan!

April 26, 2022

Vaccine Confidence Project  [to  30 Apr 2022]

http://www.vaccineconfidence.org/

News, Research and Reports

No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia  [to  30 Apr 2022]

http://www.chop.edu/centers-programs/vaccine-education-center

News

No new digest content identified.

Wellcome Trust  [to  30 Apr 2022]

https://wellcome.ac.uk/news

News. Opinion, Reports

No new digest content identified.

The Wistar Institute   [to  30 Apr 2022]

https://www.wistar.org/news/press-releases

Press Releases

No new digest content identified.

WFPHA: World Federation of Public Health Associations  [to  30 Apr 2022]

HOME

Latest News – Blog

No new digest content identified.

World Bank [to  30 Apr 2022]

http://www.worldbank.org/en/news/all

Selected News, Announcements

COVID-19 Vaccine Inequities and Hesitancy in Iraq

Starting in August 2020, the World Bank collaborated with the World Food Programme (WFP) and implemented nine (9) rounds of the Iraq High Frequency Phone Survey (IHFPS) as part of the WFP’s monthly mVAM…

Date: April 28, 2022 Type: Publication

World Bank, Partners Launch New Fund to Spur Smart Investments in Childcare

WASHINGTON, April 28, 2022—The World Bank and government and foundation partners today launched a new program to scale up quality, affordable childcare in developing countries – a critical investment to…

Date: April 28, 2022 Type: Press Release

Keynote Address: Breaking the Cycle of Neglect and Panic

We are meeting to discuss the issues of preparedness and response after more than two years of a global Pandemic. Although the situation has improved, we still need to be cautious given the case numbers…

Date: April 27, 2022 Type: Speeches and Transcripts

[See Week in Review above for detail]

World Customs Organization – WCO  [to  30 Apr 2022]

http://www.wcoomd.org/

Latest News

No new digest content identified.

World Organisation for Animal Health (OIE)   [to  30 Apr 2022]

https://www.oie.int/en/media/news/

Press Releases, Statements

No new digest content identified.

WTO – World Trade Organisation [to  30 Apr 2022]

http://www.wto.org/english/news_e/news_e.htm

WTO News and Events [Selected]

Members discuss improving data collection on trade in essential goods to fight COVID-19

26 April 2022

The Committee on Market Access held on 26 April the second experience-sharing session on COVID-19-related goods, with members reporting on how they have monitored and measured trade in essential goods to combat the pandemic. They also discussed ways to improve data collection at a time of crisis. In addition, members explored how to promote greater international cooperation to better track the trade flows of value chains for the manufacturing of essential COVID-19-related products.

DG Okonjo-Iweala: Trade has central role in addressing food security challenges

26 April 2022

Record food prices and a worsening food security context have given new urgency to the role of trade in addressing the challenges we face today, Director-General Okonjo-Iweala said at a seminar on food security organized by the WTO on 26 April. In her opening remarks, she said the event provided an opportunity to deepen understanding of the issues at stake and to help members take concrete steps forward so that trade can contribute to the attainment of food security around the world.

::::::

ARM [Alliance for Regenerative Medicine]  [to  30 Apr 2022]

Press Releases

Selected Press Releases

Alliance for Regenerative Medicine Announces CEO Transition

April 27, 2022   WASHINGTON, DC

   Janet Lynch Lambert will step down as the CEO of the Alliance for Regenerative Medicine after guiding the leading international advocacy organization for cell, gene and tissue-engineered therapies through five years of extraordinary growth in membership, funding, and influence. In Lambert’s time as the CEO of ARM, the membership doubled to more than 425 diverse global members and the organization’s budget and full-time staff tripled…The ARM board has constituted an 8-person Search Committee to conduct the search for a CEO successor, and Lambert is a key member of that committee. Executive search firm Catalyst Advisors, led by Partner Gilbert Forest, has been retained to support the search….

BIO    [to  30 Apr 2022]

https://www.bio.org/press-releases

Press Release

BIO Statement on USTR Special 301 Report

April 29, 2022

USTR this week released its 2022 Special 301 Report. BIO, after reviewing the report, released the following statement:

   “We welcome USTR’s efforts to address IP-related concerns for U.S.-based biotech enterprises in China, especially concerning China’s coercive technology transfer policies, patent prosecution, and patent enforcement obstacles. USTR’s emphasis on monitoring China’s progress in implementing its Phase One Agreement commitments to address these longstanding IP matters is encouraging…”

DCVMN – Developing Country Vaccine Manufacturers Network  [to  30 Apr 2022]

http://www.dcvmn.org/

News; Upcoming events

No new digest content identified.

ICBA – International Council of Biotechnology Associations   [to  30 Apr 2022]

https://internationalbiotech.org/news/

News

No new digest content identified.

IFPMA   [to  30 Apr 2022]

http://www.ifpma.org/resources/news-releases/

Selected Press Releases, Statements, Publications

Celebrating World IP Day with a focus on youth and innovation

26 April 2022

International Generic and Biosimilar Medicines Association [IGBA]

https://www.igbamedicines.org/

News

No new digest content identified.

International Alliance of Patients’ Organizations – IAPO  [to  30 Apr 2022]

https://www.iapo.org.uk/news/topic/6

Press and media [Selected]

No new digest content identified.

PhRMA    [to  30 Apr 2022]

http://www.phrma.org/

Latest News [Selected]

No new digest content identified.

Journal Watch

Posted on by

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org